- Home
- XTNT vs ECOR Comparison
XTNT vs ECOR Comparison
Compare XTNT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ECOR
- Stock Information
- Founded
- XTNT N/A
- ECOR 2005
- Country
- XTNT United States
- ECOR United States
- Employees
- XTNT N/A
- ECOR N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XTNT Health Care
- ECOR Health Care
- Exchange
- XTNT Nasdaq
- ECOR Nasdaq
- Market Cap
- XTNT 60.9M
- ECOR 57.5M
- IPO Year
- XTNT N/A
- ECOR 2018
- Fundamental
- Price
- XTNT $0.45
- ECOR $5.68
- Analyst Decision
- XTNT Strong Buy
- ECOR Strong Buy
- Analyst Count
- XTNT 1
- ECOR 2
- Target Price
- XTNT $3.00
- ECOR $25.50
- AVG Volume (30 Days)
- XTNT 29.4K
- ECOR 211.7K
- Earning Date
- XTNT 05-14-2025
- ECOR 05-07-2025
- Dividend Yield
- XTNT N/A
- ECOR N/A
- EPS Growth
- XTNT N/A
- ECOR N/A
- EPS
- XTNT N/A
- ECOR N/A
- Revenue
- XTNT $117,267,000.00
- ECOR $25,182,000.00
- Revenue This Year
- XTNT $15.56
- ECOR $32.20
- Revenue Next Year
- XTNT $22.39
- ECOR $46.27
- P/E Ratio
- XTNT N/A
- ECOR N/A
- Revenue Growth
- XTNT 28.44
- ECOR 57.09
- 52 Week Low
- XTNT $0.33
- ECOR $5.09
- 52 Week High
- XTNT $1.03
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- XTNT 38.67
- ECOR 18.62
- Support Level
- XTNT $0.45
- ECOR $5.23
- Resistance Level
- XTNT $0.50
- ECOR $7.05
- Average True Range (ATR)
- XTNT 0.04
- ECOR 0.56
- MACD
- XTNT -0.00
- ECOR 0.02
- Stochastic Oscillator
- XTNT 0.00
- ECOR 1.36
Stock Price Comparison Chart: XTNT vs ECOR
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.